Indian pharma firms pivot towards diversification amid US generics slowdown

India’s leading drugmakers are shifting focus from US generics to domestic sales, emerging markets, and innovative therapies, signalling a strategic industry transformation driven by US market pressures and international growth opportunities. India’s biggest pharmaceutical companies are leaning more heavily on…















